J Korean Med Assoc Search

CLOSE


J Korean Med Assoc > Volume 60(10); 2017 > Article
Lee and Kim: Pharmacological therapy of nocturnal enuresis

Abstract

Nocturnal enuresis is a common problem of children during sleeping at preschool or school age. It may affect negatively the psychosocial development of children. Children with enuresis may have lower self-esteem and lower quality of life. There are three main factors of the pathophysiology of enuresis: high nocturnal urine production, nocturnal low bladder capacity or increased detrusor muscle activity, and arousal disorder. As pharmacological therapy for nocturnal enuresis, several medications including desmopressin, anticholinergics, imipramine have been used for a long time. As first-line therapy, desmopressin combined with anticholinergics has good response in primary monosymptomatic nocturnal enuresis. Because imipramine has serious and lethal cardiotoxic effect with overdosage, imipramine should be prescribed after EKG to rule out the conduction problem of heart.

References

1. Lundgren R. Nocturia: a new perspective on an old symptom. Scand J Urol Nephrol 2004;38:112-116.
crossref pmid
2. Ozden C, Ozdal OL, Altinova S, Oguzulgen I, Urgancioglu G, Memis A. Prevalence and associated factors of enuresis in Turkish children. Int Braz J Urol 2007;33:216-222.
crossref pmid
3. Butler RJ, Golding J, Northstone K. ALSPAC Study Team. Nocturnal enuresis at 7.5 years old: prevalence and analysis of clinical signs. BJU Int 2005;96:404-410.
crossref pmid
4. Hong CH, Baek MK, Lee SH, Lee JW, Pai KS. Diagnosis and treatment of nocturnal enuresis in children. Korean J Pediatr 2008;11:1140-1146.
crossref
5. Neveus T, Eggert P, Evans J, Macedo A, Rittig S, Tekgul S, Vande Walle J, Yeung CK, Robson L. International Child-ren's Continence Society. Evaluation of and treatment for monosymptomatic enuresis: a standardization document from the International ChildrenXMLLink_XYZs Continence Society. J Urol 2010;183:441-447.
pmid
6. Kamperis K, Rittig S, Radvanska E, Jorgensen KA, Djurhuus JC. The effect of desmopressin on renal water and solute handling in desmopressin resistant monosymptomatic noc-turnal enuresis. J Urol 2008;180:707-713.
crossref pmid
7. Juul KV, Van Herzeele C, De Bruyne P, Goble S, Walle JV, Norgaard JP. Desmopressin melt improves response and compliance compared with tablet in treatment of primary monosymptomatic nocturnal enuresis. Eur J Pediatr 2013;172:1235-1242.
crossref pmid pmc pdf
8. Robson WL, Leung AK, Norgaard JP. The comparative safety of oral versus intranasal desmopressin for the treatment of children with nocturnal enuresis. J Urol 2007;178:24-30.
crossref pmid
9. Hjalmas K, Hanson E, Hellstrom AL, Kruse S, Sillen U. Long-term treatment with desmopressin in children with primary monosymptomatic nocturnal enuresis: an open multicentre study. Swedish Enuresis Trial (SWEET) Group. Br J Urol 1998;82:704-709.
pmid
10. Lister-Sharp D, O'Meara S, Bradley M, Sheldon TA. A systematic review of the effectiveness of interventions for managing childhood nocturnal enuresis. York: University of York; 1997.

11. Yeung CK, Sit FK, To LK, Chiu HN, Sihoe JD, Lee E, Wong C. Reduction in nocturnal functional bladder capacity is a common factor in the pathogenesis of refractory nocturnal enuresis. BJU Int 2002;90:302-307.
crossref pmid
12. Lovering JS, Tallett SE, McKendry JB. Oxybutynin efficacy in the treatment of primary enuresis. Pediatrics 1988;82:104-106.
crossref pmid pdf
13. Austin PF, Ferguson G, Yan Y, Campigotto MJ, Royer ME, Coplen DE. Combination therapy with desmopressin and an anticholinergic medication for nonresponders to desmopressin for monosymptomatic nocturnal enuresis: a randomized, double-blind, placebo-controlled trial. Pediatrics 2008;122:1027-1032.
crossref pmid pdf
14. Nijman RJ, Butler R, van Gool J, Yeung CK, Bower W, Hjalmas K. Conservative management of urinary inconti-nence in children. In: Abrams P, Cardozo L, Khoury S, Wein A, editor. Incontinence. 2nd ed. Plymouth: Health Publi-cation; 2002. p. 515-551.

15. Hjalmas K, Arnold T, Bower W, Caione P, Chiozza LM, von Gontard A, Han SW, Husman DA, Kawauchi A, LAckgren G, Lottmann H, Mark S, Rittig S, Robson L, Walle JV, Yeung CK. Nocturnal enuresis: an international evidence based manage-ment strategy. J Urol 2004;171((6 Pt 2):2545-2561.
crossref
16. Neveus T, Tullus K. Tolterodine and imipramine in refractory enuresis: a placebo-controlled crossover study. Pediatr Neph-ro 2008;23:263-267.
crossref pdf
17. Glazener CM, Evans JH. Simple behavioural and physical interventions for nocturnal enuresis in children. Cochrane Database Syst Rev 2004;(2):CD003637.
crossref pmid
18. Park SJ, Park JM, Pai KS, Ha TS, Lee SD, Baek M. Korean Children's Continence and Enuresis Society. Desmopressin alone versus desmopressin and an anticholinergic in the first-line treatment of primary monosymptomatic nocturnal enu-resis: a multicenter study. Pediatr Nephrol 2014;29:1195-1200.
crossref pmid pdf
Table 1

Anticholinergics for nocturnal enuresis

jkma-60-796-i001-l.jpg


ABOUT
ARTICLE CATEGORY

Browse all articles >

ARCHIVES
FOR CONTRIBUTORS
Editorial Office
37 Ichon-ro 46-gil, Yongsan-gu, Seoul
Tel: +82-2-6350-6562    Fax: +82-2-792-5208    E-mail: jkmamaster@gmail.com                

Copyright © 2024 by Korean Medical Association.

Developed in M2PI

Close layer
prev next